Inventor
WELCHER ANDREW A
US19 patents
⚠️ This page may combine multiple inventors who share the name “WELCHER ANDREW A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
16 patentsUS5981245ANov 9, 1999
EPH-like receptor protein tyrosine kinases
AMGEN INC178 citations98
US5824303AOct 20, 1998
Eck receptor ligands
AMGEN INC61 citations95
US7335743B2Feb 26, 2008
Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
AMGEN INC45 citations93
US7790859B2Sep 7, 2010
Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
AMGEN INC24 citations92
US5981246ANov 9, 1999
Nucleic acids encoding EPH-like receptor protein tyrosine kinases
AMGEN INC21 citations92
US5650504AJul 22, 1997
Nucleic acids encoding eck receptor ligands
AMGEN INC24 citations92
US8906371B2Dec 9, 2014
Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
AMGEN INC3 citations73
US5716934AFeb 10, 1998
Eck receptor ligands
AMGEN INC13 citations73
US7041796B2May 9, 2006
C3b/C4b Complement Receptor-like molecules and uses thereof
AMGEN INC7 citations72
US11230597B2Jan 25, 2022
Methods of treatment using an interferon gamma inhibitor
AMGEN INC4 citations64
US6992175B1Jan 31, 2006
Nucleic acids encoding Eph-like receptor tyrosine kinases
AMGEN INC4 citations62
US6656707B2Dec 2, 2003
C3b/C4b complement receptor-like molecules and uses thereof
AMGEN INC2 citations61
US6479250B1Nov 12, 2002
Eck receptor ligands
AMGEN INC2 citations61
US11156600B2Oct 26, 2021
Assay for detecting TH1 and TH2 cell populations
AMGEN INC0 citations53
US6087167AJul 11, 2000
Eck receptor ligands
AMGEN INC0 citations51
US10156562B2Dec 18, 2018
Assay for detecting Th1 and Th2 cell populations
AMGEN INC0 citations42
WELCHER ANDREW A
2 patentsUS8529893B2Sep 10, 2013
Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors
WELCHER ANDREW A4 citations71
US8202976B2Jun 19, 2012
Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors
WELCHER ANDREW A2 citations58